With a $2.1 million grant from the U.S. Centers for Disease Control and Prevention, researchers from the Johns Hopkins School of Medicine are studying how the emocha mobile app and web platform–in combination with a cash reward–could potentially improve medication adherence for patients combatting opioid use disorder. “Effective, safe, and accessible solutions must be considered to end the opioid epidemic…technology such as video Directly Observed Therapy offers near real-time insights into a patient’s adherence and response to medication, enabling providers to better tailor care plans and support retention in treatment,” said Robert C. Bollinger, MD, MPH, Professor of Medicine at Johns Hopkins and founder of emocha’s technology. 

Read the full article from mHealthIntelligence